These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9117460)

  • 21. Human T-lymphotropic virus type II RFLP subtypes a0 and b4/b5 are associated with different demographic and geographic characteristics in the United States.
    Liu H; Leung P; Glynn S; Murphy EL
    Virology; 2001 Jan; 279(1):90-6. PubMed ID: 11145892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population.
    Soares BC; Proietti AB; Proietti FA;
    Rev Saude Publica; 2003 Aug; 37(4):470-6. PubMed ID: 12937708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance.
    O'Brien SF; Ehsani-Moghaddam B; Goldman M; Osmond L; Fan W; Drews SJ
    Can J Public Health; 2024 Aug; 115(4):611-621. PubMed ID: 38743354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SHTLV-I/II seroprevalence in blood donors of Hospital Pablo Tobón Uribe Blood Bank during the period 2014-2015].
    Muñoz M; Carvalho S; Donado JH; Barco GE; Jaramillo S
    Biomedica; 2018 Mar; 38(1):37-41. PubMed ID: 29668132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection.
    Zaaijer HL; Cuypers HT; Dudok de Wit C; Lelie PN
    Transfusion; 1994 Oct; 34(10):877-80. PubMed ID: 7940659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.
    Toro C; Soriano V; Tuset C; Aguilera A; Caballero E; de Lejarazu RO; Rodés B;
    HIV Clin Trials; 2002; 3(5):397-402. PubMed ID: 12407489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques.
    Balkhy HH; Memish ZA; Abed E; Qasem L; Amer AB; Masoud S; Hajeer AH
    Mil Med; 2004 Mar; 169(3):251-3. PubMed ID: 15080248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
    Dezzutti CS; Guenthner PC; Daniel S; Utz U; Cabrera T; Marshall JH; Bianco C; Lal RB; Cowan EP
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece.
    Dalekos GN; Zervou E; Karabini F; Elisaf M; Bourantas K; Siamopoulos KC
    Transfusion; 1995 Jun; 35(6):503-6. PubMed ID: 7770902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study.
    Guiltinan AM; Murphy EL; Horton JA; Nass CC; McEntire RL; Watanabe K
    Transfusion; 1998; 38(11-12):1056-62. PubMed ID: 9838938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivity.
    Re MC; Furlini G; Ramazzotti E; D'Antuono A; Vignoli M; La Placa M; Monari P; Zauli G; La Placa M
    New Microbiol; 1993 Oct; 16(4):373-9. PubMed ID: 7903409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
    Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
    J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK; Bhatti FA; Salamat N
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS).
    Murphy EL; Bryzman SM; Glynn SA; Ameti DI; Thomson RA; Williams AE; Nass CC; Ownby HE; Schreiber GB; Kong F; Neal KR; Nemo GJ
    Hepatology; 2000 Mar; 31(3):756-62. PubMed ID: 10706569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations.
    Kleinman S; Swanson P; Allain JP; Lee H
    Transfusion; 1993 Jan; 33(1):14-8. PubMed ID: 8424263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T-lymphotropic virus antibody screening of blood donors: rates of false-positive results and evaluation of a potential donor reentry algorithm.
    Stramer SL; Notari EP; Zou S; Krysztof DE; Brodsky JP; Tegtmeier GE; Dodd RY
    Transfusion; 2011 Apr; 51(4):692-701. PubMed ID: 20946198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4.
    Bagossi P; Bander P; Bozóki B; Tözsér J
    Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1235-49. PubMed ID: 19968515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies.
    Césaire R; Bera O; Maier H; Lezin A; Martial J; Ouka M; Kerob-Bauchet B; Ould Amar AK; Vernant JC
    Transfusion; 1999 Oct; 39(10):1145-9. PubMed ID: 10532611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.